Clinical trials
Phase 4 Glomerulonephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 4 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| Astellas Pharma Korea, Inc. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Chinese PLA General Hospital | 1 |
| Christian Medical College, Vellore, India | 1 |
| Fondazione Schena | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Jemincare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis | 17 |
| Glomerulonephritis, IGA | 5 |
| Proteinuria | 4 |
| Lupus Nephritis | 3 |
| Nephritis | 3 |
| Renal Insufficiency, Chronic | 3 |
| Autoimmune Diseases | 2 |
| Glomerulonephritis, Membranous | 2 |
| IgA Vasculitis | 2 |
| Kidney Diseases | 2 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.